Our Investment Thesis
We are committed to leading the future of skin health innovation by identifying, nurturing, and scaling high-growth skincare technologies in dermatology, aesthetics, and skincare. Our goal is to build unprecedented value for patients and consumers by investing in cutting-edge solutions that shape the industry’s future.
Early-Stage Investment Basics
Investment Stages
We focus on early-stage investments in Pre-Seed (Angel), Seed, and Series A/B funding rounds. Additionally, investors take on an active advisory role, providing strategic guidance to help startups scale successfully.
Investment Vehicles
Our funding strategies include Convertible Notes and SAFE Notes, two widely used investment vehicles in early-stage skincare and dermatology startups:
- Convertible Notes: A short-term loan that converts into shares during a future equity round, offering flexibility for both startups and investors.
- SAFE Notes: A simple agreement for future equity, functioning as an interest-free loan that converts into stock at the first priced equity round.
By leveraging these early-stage funding strategies, we support innovative skincare, dermatology, and aesthetics companies, helping them scale and succeed in a competitive market.